Medindia

X

Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar

Wednesday, January 7, 2009 General News J E 4
Advertisement
RICHMOND, Va., Jan. 7 Dr. Ryan Burnette, Director of Alliance Biosciences will lead a trade mission to Singapore January 19, 2009 through January 23, 2009. Dr. Burnette will be promoting the need for international accreditation processes for high-containment biomedical labs as a lynchpin to an effective biosecurity and biosafety preparedness program.



"I am very excited to visit Singapore, a progressive country that has embraced the need for well-designed and operated containment labs and operations," said Dr. Burnette. "I look forward to meeting with academic, governmental and private sector leaders to discuss ways to utilize solid accreditation standards as a foundation for best practices in research and manufacturing, and to partially mitigate the risks of bio-terrorism."



During his visit, Dr. Burnette will speak at the Lab Design Seminar taking place January 19th - 20th at Biopolis, the biomedical R&D hub at one-north, a 200 hectare vibrant hotspot for R&D innovation and test-bedding. Organized by JTC Corporation, the master developer for one-north, the inaugural seminar, a first for Singapore, will be the ideal networking forum for international thought leaders, scientists, developers and other professionals to come together to exchange invaluable insights and experiences on specialty lab design.



"Biopolis has seeded the Biomedical research industry in Singapore and garnered international attention," said Philip Su, Assistant Chief Executive Officer, JTC Corporation. "We are privileged to have Dr. Burnette speak at this event, which will encourage greater sharing between design professionals from all over the world, and break boundaries between different international practices."



On January 20th at 4:15pm, Dr. Burnette will deliver a presentation titled "Working Toward Accreditation Standards". The speech will highlight the significant need for international accreditation standards for high-containment biomedical labs, and will discuss the major similarities and differences of efforts underway in Europe, Canada, the U.S. and other countries to develop benchmarks for design and operational standards of excellence.



"JTC Corporation has created a tremendous forum for international leaders to convene, share ideas and best practices," stated Burnette. "With increased awareness of the need for accreditation standards we will continue to progress toward developing such a platform."



For further information on the trade mission please visit www.alliancebiosciences.com or email info@alliancebiosciences.com. For conference registration information please visit http://www.one-north.com or email one-north@jtc.gov.sg.



About Alliance Biosciences

Alliance Biosciences is the leading biosafety consulting firm in the U.S., addressing the various needs of the biotechnology, pharmaceutical and R&D industries. Serving a diverse clientele in academia, the private and public sectors, Alliance Biosciences provides high-containment laboratory design (BSL -1/2/3/4) guidance, facility inspections and recommendations, operational audits of documentation and SOPs, risk assessments and custom biosafety training curricula. The firm is a division of Alliance Engineering, Inc., enabling the efficient translation of client needs from concept through construction. Led by internationally recognized industry experts, Alliance Biosciences delivers a truly full-service, turnkey approach to biosafety program management. www.alliancebiosciences.com



About one-north

one-north is Singapore's icon of the knowledge economy. It serves to provide an intellectually stimulating and creative environment for entrepreneurs, scientists and researchers to congregate, interact and exchange ideas; an exceptional place where this thriving community will work, live, play and learn. With a focus on knowledge-intensive activities in the biomedical, infocomms and media industries, it is slated to be a vibrant hotspot for innovation and test bedding.



Covering almost 200 hectares, one-north will be developed in phases over a period of 15 to 20 years, integrating residential units, commercial hubs, tertiary and research institutes, sports facilities as well as green lungs. It is strategically located in the Buona Vista area (southern part of Singapore) near the National University of Singapore and Singapore Science Park and aims to be a focal point for research and development and technopreneurial activities.



JTC Corporation was appointed master developer for this project in September 2000.



one-north's home page address on the World Wide Web is http://www.one-north.com



SOURCE Alliance Biosciences
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Osteotech Initiates Pivotal Clinical Trial for Dur...
S
Daiichi Sankyo, Inc. Establishes Subsidiary in Pue...